These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12148526

  • 1. Report on epoetin use in oncology is precursor to guidelines.
    Levenson D.
    Rep Med Guidel Outcomes Res; 2001 May 31; 12(11):8-9. PubMed ID: 12148526
    [No Abstract] [Full Text] [Related]

  • 2. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun 31; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human erythropoietin in pediatric oncology: a review.
    Feusner J, Hastings C.
    Med Pediatr Oncol; 2002 Oct 31; 39(4):463-8. PubMed ID: 12203665
    [Abstract] [Full Text] [Related]

  • 4. Suboptimal hemoglobin levels: do they impact patients and their therapy? Audience responses.
    Ludwig H, Pecorelli S.
    Semin Oncol; 2000 Apr 31; 27(2 Suppl 4):18-9. PubMed ID: 10847304
    [No Abstract] [Full Text] [Related]

  • 5. Epoetin alfa: future directions and future research.
    Ludwig H, Hudis CA, Goss G, Leyland-Jones B.
    Oncologist; 2004 Apr 31; 9 Suppl 5():70-3. PubMed ID: 15591424
    [No Abstract] [Full Text] [Related]

  • 6. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.
    Oncologist; 2004 Apr 31; 9(1):90-6. PubMed ID: 14755018
    [Abstract] [Full Text] [Related]

  • 7. Response to the publication: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Gascón P, Ludwig H.
    Eur J Cancer; 2005 Dec 31; 41(18):2789-91. PubMed ID: 16253500
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of cancer-related anemia with epoetin alfa: a review.
    Ferrario E, Ferrari L, Bidoli P, De Candis D, Del Vecchio M, De Dosso S, Buzzoni R, Bajetta E.
    Cancer Treat Rev; 2004 Oct 31; 30(6):563-75. PubMed ID: 15325036
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimal hemoglobin levels for cancer patients.
    Itri LM.
    Semin Oncol; 2000 Apr 31; 27(2 Suppl 4):12-5; discussion 16-7. PubMed ID: 10847303
    [No Abstract] [Full Text] [Related]

  • 11. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb 31; 11(2):197-205. PubMed ID: 16476840
    [Abstract] [Full Text] [Related]

  • 12. [Anaemia treatment in gynaecology: use of epoetin in onco-gynaecology and gynaecological surgery].
    Kirchner V, Anaemia Working Group.
    Rev Med Suisse; 2005 Apr 13; 1(15):1041-3, 1046-7. PubMed ID: 15918284
    [Abstract] [Full Text] [Related]

  • 13. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
    Henry DH, Bowers P, Romano MT, Provenzano R.
    Arch Intern Med; 2004 Feb 09; 164(3):262-76. PubMed ID: 14769622
    [Abstract] [Full Text] [Related]

  • 14. Clinical guidelines for the treatment of cancer-related anemia.
    Koeller JM.
    Pharmacotherapy; 1998 Feb 09; 18(1):156-69. PubMed ID: 9469689
    [Abstract] [Full Text] [Related]

  • 15. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    Chang J, Couture F, Young S, McWatters KL, Lau CY.
    J Clin Oncol; 2005 Apr 20; 23(12):2597-605. PubMed ID: 15452188
    [Abstract] [Full Text] [Related]

  • 16. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS.
    J Am Geriatr Soc; 2008 Aug 20; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract] [Full Text] [Related]

  • 17. Quality of life and anemia: the nephrology experience.
    Macdougall IC.
    Semin Oncol; 1998 Jun 20; 25(3 Suppl 7):39-42. PubMed ID: 9671329
    [Abstract] [Full Text] [Related]

  • 18. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, Ahuja M, Riaz S, Akamah J.
    J Am Geriatr Soc; 2007 Oct 20; 55(10):1557-65. PubMed ID: 17697104
    [Abstract] [Full Text] [Related]

  • 19. Anemia: dialysis patients experiences.
    Schatell D, Witten B.
    Nephrol News Issues; 2004 Nov 20; 18(12):49-54. PubMed ID: 15595502
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.